Monthly Archives: June 2015
Risk minimisation activities: What you need to know
Risk minimisation activities are required for each safety concern of a product listed in a Risk management Plan (RMP). These are interventions that aim to optimise the benefit-risk balance of a drug by minimising its risks in clinical practice. Risk … Continue reading
Risk Management Plans: Advice from the TGA
Members of our Drug Safety team were very interested to hear from the TGA at the 2015 ARCS Scientific Congress on the issue of Risk Minimisation Plans. Risk Management Plans (RMPs) are deemed necessary given that clinical trials generally cannot … Continue reading
Commercial Eyes Recruiting: Information and Communications Technology Specialist
Our Business Services group is looking for an Information and Communications Technology (ICT) Specialist to take the lead and be the ICT expert within the organisation. This is a full time position that will report directly to our Finance Director … Continue reading
Funding pathways for new technologies
Recently, the topic of funding pathways for new technologies was discussed as part of a speaker session at the 2015 ARCS Scientific Congress, at Royal Randwick Sydney. Professor Robyn Ward, the current Chairperson of MSAC and a member of the … Continue reading
Consumer Medicines Information: We can do better than Dr Google
Many people consult Dr Google about their medicines far, far more than their GP. In fact, one in 20 of Google’s 100 billion monthly searches are for health or medicine-related information. The doctor-patient relationship is evolving with patients wanting (and … Continue reading
